Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › PA › HANOVER › HANOVER PEDIATRIC ASSOCIATES, P.C.

HANOVER PEDIATRIC ASSOCIATES, P.C.

NPI: 1891721064 · HANOVER, PA 17331 · Pediatrics Physician · NPI assigned 06/23/2006

$2.70M
Total Medicaid Paid
136,057
Total Claims
123,141
Beneficiaries
61
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMASUCCI, DOUGLAS (PRESIDENT)
NPI Enumeration Date06/23/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 838 $40K
2019 573 $19K
2020 3,535 $94K
2021 31,266 $626K
2022 34,346 $653K
2023 35,519 $668K
2024 29,980 $600K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 25,496 22,421 $929K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3,980 3,847 $331K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 3,354 3,259 $265K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,389 2,280 $204K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,042 3,730 $203K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,972 1,898 $151K
99051 3,514 3,364 $119K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3,355 3,251 $115K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 6,699 3,269 $75K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 6,029 5,715 $54K
92551 7,036 6,781 $41K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1,125 1,081 $40K
87081 4,816 4,613 $24K
99173 6,015 5,843 $24K
87634 287 268 $19K
90686 2,237 2,173 $16K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 303 299 $8K
D0120 Periodic oral evaluation - established patient 376 362 $8K
87428 241 233 $7K
90648 2,143 2,057 $6K
99188 439 433 $6K
90670 1,541 1,500 $6K
90460 Immunization administration through 18 years of age via any route, first or only component 462 294 $5K
92015 Determination of refractive state 939 932 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 266 240 $4K
90723 1,078 1,038 $4K
90680 1,377 1,343 $4K
90633 1,178 1,123 $3K
90710 1,172 1,134 $3K
96127 2,982 2,511 $3K
80061 Lipid panel 1,406 1,288 $3K
87807 160 157 $2K
96160 2,722 2,560 $2K
94760 9,087 8,262 $2K
90734 737 685 $1K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2,979 2,133 $1K
90715 821 717 $1K
81003 387 370 $1K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 16 16 $1K
90696 378 366 $880.00
83655 4,751 4,488 $552.71
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 45 43 $462.32
90651 404 383 $370.00
85018 999 944 $341.46
90620 212 189 $253.84
90700 180 177 $231.00
A7006 Administration set, with small volume filtered pneumatic nebulizer 64 58 $207.12
96161 1,436 1,382 $194.32
90461 29 27 $183.74
92567 12 12 $118.32
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 74 73 $3.12
36416 1,007 889 $2.73
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 56 41 $0.32
3078F 4,704 4,455 $0.00
90672 14 14 $0.00
J7614 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg 13 12 $0.00
3074F 4,808 4,546 $0.00
D9999 Unspecified adjunctive procedure, by report 632 502 $0.00
85013 200 199 $0.00
90677 524 504 $0.00
90656 357 357 $0.00